Gene therapy using non-viral peptide vector in a canine systemic lupus erythematosus model

Veterinary Immunology and Immunopathology

Volumn 103, Issue 3-4, 2005, Pages 223-233

  Choi, Eun Wha ^a,b   Shin, Il Seob ^a,b   Youn, Hwa Young ^a,b   Kim, Dae Yong ^a,b   Lee, Hang ^a,b   Chae, Young Jin ^c   Lee, Chang Woo ^a  

^a Seoul National University   (South Korea)

^b Seoul National University   (South Korea)

^c Goyang City Kyunggi Do 411 380 S ^*  (South Korea)

Author keywords

Costimulation; CTLA 4; Dog; Non viral peptide vector; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CREATININE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GROWTH HORMONE; IMMUNOGLOBULIN A; PEPTIDE; PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE URINE LEVEL; CYTOMEGALOVIRUS; DISEASE MODEL; DOG; EXPERIMENTAL MODEL; GENE CONSTRUCT; GENE INSERTION; GENE THERAPY; HISTOLOGY; HOST; IMMUNE RESPONSE; MALE; NONHUMAN; POLYADENYLATION; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN URINE LEVEL; SKIN; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; AUTOANTIBODIES; CREATININE; DOG DISEASES; DOGS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE THERAPY; GENETIC VECTORS; HISTOCYTOCHEMISTRY; IMMUNOGLOBULIN CONSTANT REGIONS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

BOVINAE; CANIS FAMILIARIS; CYTOMEGALOVIRUS;

EID: 11144328348     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.09.027     Document Type: Article

References (33)

1. J.E. Balow, and H.A. Austin 3rd. Progress in the treatment of proliferative lupus nephritis Curr. Opin. Nephrol. Hypertens. 9 2 2000 107 115
2. B.R. Blazar, P.A. Taylor, P.S. Linsley, and D.A. Vallera In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice Blood 83 1994 3815 3825
3. C. Bordignon, L.D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati, P. Panina, E. Mazzolari, D. Maggioni, C. Rossi, and P. Servida Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients Science 270 1995 470 475
4. T. Cartmell, T. Southgate, G.S. Rees, M.G. Castro, P.R. Lowenstein, and G.N. Luheshi Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain J. Neurosci. 19 1999 1517 1523
5. E.A. Clark, and J.A. Ledbetter How B and T cells talk to each other Nature 367 1994 425 428
6. Y. Dai, E.M. Schwarz, D. Gu, W.W. Zhang, N. Sarvetnick, and I.M. Verma Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression Proc. Natl. Acad. Sci. U.S.A. 92 1995 1401 1405
7. M.J. Day Multisystem and intercurrent immune-mediated disease: systemic lupus erythematosus M.J. Day Clinical Immunology of the Dog and Cat 1999 Manson Publishing London 243 247
8. P. Faaber, T.P. Rijke, L.B. Van De Putte, P.J. Capel, and J.H. Berden Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes J. Clin. Invest. 77 1986 1824 1830
9. B.K. Finck, P.S. Linsley, and D. Wofsy Treatment of murine lupus with CTLA4Ig Science 265 1994 1225 1227
10. G.J. Freeman, D.B. Lombard, C.D. Gimmi, S.A. Brod, K. Lee, J.C. Laning, D.A. Hafler, M.E. Dorf, G.S. Gray, H. Reiser, C.H. June, C.B. Thompson, and L.M. Nadler CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production J. Immunol. 149 1992 3795 3801
11. C.D. Gimmi, G.J. Freeman, J.G. Gribben, G. Gray, and L.M. Nadler Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation Proc. Natl. Acad. Sci. U.S.A. 90 1993 6586 6590
12. R.E.W. Halliwell, and N.T. Gorman Autoimmune blood disease: SLE in the dog R.E.W. Halliwell N.T. Gorman Veterinary Clinical Immunology 1989 W.B. Saunders Co. Philadelphia 327 333
13. C.H. June, J.A. Ledbetter, P.S. Linsley, and C.B. Thompson Role of the CD28 receptor in T-cell activation Immunol. Today 11 1990 211 216
14. S. Laquerre, W.F. Goins, S. Motiuchi, T.J. Oligino, D.M. Krisky, J.C. Marconi, M.K. Soares, J.B. Cohen, and D.J. Fink Gene-transfer tool: herpes simplex virus vectors T. Friedman The Development of Human Gene Therapy 1999 Cold Spring Harbor Laboratory Press New York 173 203
15. D.J. Lenschow, Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg Science 257 1992 789 792
16. H. Lin, S.F. Bolling, P.S. Linsley, R.Q. Wei, D. Gordon, C.B. Thompson, and L.A. Turka Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion J. Exp. Med. 178 1993 1801 1806
17. P.S. Linsley, E.A. Clark, and J.A. Ledbetter T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1 Proc. Natl. Acad. Sci. U.S.A. 87 1990 5031 5035
18. P.S. Linsley, W. Brady, M. Urnes, L.S. Grosmaire, N.K. Damle, and J.A. Ledbetter CTLA-4 is a second receptor for the B cell activation antigen B7 J. Exp. Med. 174 1991 561 569
19. P.S. Linsley, P.M. Wallace, J. Johnson, M.G. Gibson, J.L. Greene, J.A. Ledbetter, C. Singh, and M.A. Tepper Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule Science 257 1992 792 795
20. J.A. Lott, V.A. Stephan, and K.A. Pritchard Evaluation of the coomassie brilliant blue G-250 method for urinary protein Clin. Chem. 29 11 1983 1946 1950
21. P.R. Lowenstein, E.E. Morrison, D. Bain, P. Hodge, C.M. Preston, P. Clissold, N.D. Stow, T.A. Mckee, and M.G. Castro Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro Neuroscience 60 1994 1059 1077
22. D.J. Meyer, E.H. Coles, and L.J. Rich Tests for immune-mediated disease L. Mills Veterinary Laboratory Medicine Interpretation and Diagnosis 1992 W.B. Saunders Co. Philadelphia 139 141
23. D.L. Mueller, M.K. Jenkins, and R.H. Schwartz Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy Annu. Rev. Immunol. 7 1989 445 480
24. Y. Naparstek, A. Ben-Yehuda, M.P. Madaio, R. Bar-Tana, L. Schuger, G. Pizov, Z.V. Neeman, and I.R. Cohen Binding of anti-DNA antibodies and inhibition of glomerulonephritis in MRLlpr/lpr mice by heparin Arthritis Rheum. 33 1990 1554 1559
25. W. Ofosu-Appiah, G. Sfeir, D. Viti, and E. Burashnikova Induction of systemic lupus erythematosus-like disease in mice by immunization with heparan sulfate Cell. Immunol. 183 1998 22 31
26. S. Paterson Immunologic skin diseases S. Paterson Skin Diseases of the Dog 1998 Blackwell Science Ltd Oxford 175 179
27. C.H. Sodikoff Urine tests C.H. Sodikoff Laboratory Profiles of Small Animal Diseases. A Guide to Laboratory Diagnosis second ed. 1995 Mosby St. Louis 50
28. D. Stone, A. David, F. Bolognani, P.R. Lowenstein, and M.G. Castro Viral vectors for gene delivery and gene therapy within the endocrine system J. Endocrinol. 164 2 2000 103 118
29. N. Suzuki, T. Harada, Y. Mizushima, and T. Sakane Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus J. Immunol. 151 1993 1128 1136
30. L.A. Turka, P.S. Linsley, H. Lin, W. Brady, J.M. Leiden, R.Q. Wei, M.L. Gibson, X.G. Zheng, S. Myrdal, D. Gordon, T. Bailey, S.F. Bolling, and C.B. Thompson T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo Proc. Natl. Acad. Sci. U.S.A. 89 1992 11102 11105
31. S.D. White The skin as s sensor of internal medical disorder: immune-mediated disorders S.J. Ettinger E.C. Feldman Textbook of Veterinary Internal Medicine fifth ed. 2000 W.B. Saunders Co Philadelphia 29
32. S. Worgall, G. Wolff, E. Falck-Pedersen, and R.G. Crystal Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration Hum. Gene. Ther. 8 1997 37 44
33. X. Xiao, J. Li, and R.J. Samulski Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J. Virol. 70 1996 8098 8108